MDCO - Prognosis For The Medicines Company
Respect is tendered with pleasure only where it is not exacted.” - Anne Robert Jacques Turgot
Today, we take a look at a concern that is transforming itself with a new direction and CEO. The stock is well off its highs of last summer and seeing a large amount of recent insider buying.
Company Overview:
The Medicines Company (MDCO) is a Parsippany, New Jersey-based biopharmaceutical company focused on the treatment of atherosclerotic cardiovascular disease (ASCVD), the number one cause of death in the U.S. and worldwide. The company divested itself of all